ArcticZymes Technologies ASA Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

There's been a major selloff in ArcticZymes Technologies ASA (OB:AZT) shares in the week since it released its third-quarter report, with the stock down 20% to kr13.74. It looks like a pretty bad result, given that revenues fell 15% short of analyst estimates at kr24m, and the company reported a statutory loss of kr0.03 per share instead of the profit that the analysts had been forecasting. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

Check out our latest analysis for ArcticZymes Technologies

Taking into account the latest results, the current consensus from ArcticZymes Technologies' two analysts is for revenues of kr122.4m in 2025. This would reflect a solid 11% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to grow 18% to kr0.16. Before this earnings report, the analysts had been forecasting revenues of kr139.6m and earnings per share (EPS) of kr0.59 in 2025. It looks like sentiment has declined substantially in the aftermath of these results, with a real cut to revenue estimates and a pretty serious reduction to earnings per share numbers as well.

It'll come as no surprise then, to learn that the analysts have cut their price target 30% to kr16.00.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the ArcticZymes Technologies' past performance and to peers in the same industry. The period to the end of 2025 brings more of the same, according to the analysts, with revenue forecast to display 8.3% growth on an annualised basis. That is in line with its 10% annual growth over the past five years. Compare this with the broader industry (in aggregate), which analyst estimates suggest will see revenues grow 43% annually. So although ArcticZymes Technologies is expected to maintain its revenue growth rate, it's forecast to grow slower than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of ArcticZymes Technologies' future valuation.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have analyst estimates for ArcticZymes Technologies going out as far as 2026, and you can see them free on our platform here.

Plus, you should also learn about the 3 warning signs we've spotted with ArcticZymes Technologies .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.